Company: BIAF
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004915
Chunk: 17

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: DRS
Chunk 17
---
 is based on 18,248,623 shares of Common Stock outstanding as of April [ ], 2025, and excludes, as of that date the following:

| ● | 12,873,602                                                                                
 shares of Common Stock issuable upon the exercise of outstanding warrants with a weighted 
 average exercise price equal to $2.74 per share;                                          |

| ● | 304,125                                                                                    
 shares of Common Stock issuable upon the exercise of stock options issued under our equity 
 incentive plans with a weighted average exercise price equal to $6.95 per share; and       |

| ● | 1,239,531                                                                                  
 shares                                                                                     
 of our Common Stock that are reserved for equity awards that may be granted under our 2024 
 Equity Incentive Plan.                                                                     |

Unless otherwise indicated, all information contained in this prospectus assumes:

| ● | no                                                                                             
 exercise of the outstanding options, warrants, or pre-funded warrants described in the bullets 
 above;                                                                                         |

| ● | no                                                                                           
 exercise of the April 2025 Warrants or the Placement Agent Warrants issued in this offering; 
 and                                                                                          |

| ● | no                                            
 sale of Pre-Funded Warrants in this offering. |

| 5 |

<div align='center'>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

Certain statements in this prospectus may contain “forward-looking statements” within the meaning of the federal securities laws. Our forward-looking statements include, but are not limited to, statements about us and our industry, as well as statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. Additionally, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. We intend the forward-looking statements to be covered by the safe harbor provisions of the federal securities laws. Words such as “may,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, as well as statements in future tense, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based